WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009.

نویسندگان

  • Morag Ferguson
  • Jinho Shin
  • Ivana Knezevic
  • Philip Minor
  • Alan Barrett
چکیده

In May 2009, WHO convened a meeting of Working Group on Technical Specifications for Manufacturing and Evaluating Yellow Fever (YF) Vaccines, Geneva, Switzerland to initiate revision of the WHO Recommendations (formerly, Requirements) for YF vaccine published in WHO Technical Report Series number 872 (1998). The Working Group, consisting of experts from academia, industry, national regulatory authorities and national control laboratories, reviewed the latest issues of safety, efficacy and quality of YF vaccines and agreed that (i) the revision should focus on live attenuated YF vaccine virus 17D lineage; and that (ii) nonclinical and clinical guidelines for new vaccines prepared from 17D lineage be developed.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation.

There is a pressing need for guidelines focused on the clinical evaluation of dengue vaccines in exposed populations, because Phase 1 and 2 clinical trials of dengue vaccines have begun, and Phase 3 field trials may be warranted soon. In response to this need, the WHO Initiative for Vaccine Research (IVR) has conducted a series of expert consultations resulting in guidelines published as a WHO;...

متن کامل

WHO reveals its shopping list for weapons against Zika.

If viruses had ears, Zika virus would be in bad shape after listening to a WHO official describing the armamentarium the world is getting ready to launch against it. “Based on our experience with research and development during the west Africa Ebola epidemic, WHO’s [R&D] response is proceeding very quickly for Zika”, Marie-Paule Kieny, WHO Assistant Director-General, Health Systems and Innovati...

متن کامل

Swiss-CHAT: Citizens Discuss Priorities for Swiss Health Insurance Coverage

Background As universal health coverage becomes the norm in many countries, it is important to determine public priorities regarding benefits to include in health insurance coverage. We report results of participation in a decision exercise among residents of Switzerland, a high-income country with a long history of universal health insurance and deliberative democracy.   Methods We adapted the...

متن کامل

Routine vaccination with polysaccharide meningococcal vaccines is an ineffective and possibly harmful strategy

1 Coordinator, Vaccines Assessment and Monitoring, Department of Vaccines & Biologicals, World Health Organization, Geneva, Switzerland. Correspondence should be sent to this author (e-mail: [email protected]). 2 Immunization Advisor, World Health Organization, Kampala, Uganda. 3 Global Alert and Response, Department of Communicable Disease Surveillance and Response, World Health Organization...

متن کامل

Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012.

Typhoid fever is a gastrointestinal disease transmitted through the ingestion of contaminated water or food. The bacterium, Salmonella enterica subspecies enterica serovar Typhi is an important cause of illness and death in many poor countries where access to safe water and basic sanitation is limited. Humans are the only natural host and reservoir of S. Typhi. Typhoid fever causes around 21 mi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Vaccine

دوره 28 52  شماره 

صفحات  -

تاریخ انتشار 2010